What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Mycoplasma bovis in Cattle: Clinical Syndromes and Laboratory Diagnosis

Introduction

Mycoplasma bovis is a small, wall-less bacterium belonging to the class Mollicutes. It is a primary and opportunistic pathogen of cattle worldwide, causing substantial economic losses through respiratory disease, mastitis, arthritis, and other clinical manifestations [1, 2]. Unlike many bacteria, M. bovis lacks a cell wall, rendering beta-lactam antimicrobials ineffective and requiring specialized culture media for isolation [3]. The pathogen has emerged as a significant component of the Bovine Respiratory Disease Complex (BRD), often in combination with viral agents such as Bovine Coronavirus and Bovine Respiratory Syncytial Virus (BRSV) [4, 5]. This article provides an exhaustive review of the clinical syndromes associated with M. bovis in beef and dairy cattle and critically evaluates laboratory diagnostic methods, including culture, molecular detection, serology, and antimicrobial susceptibility testing.

Clinical Syndromes

Respiratory Disease

M. bovis is a leading cause of chronic pneumonia and otitis media in feedlot cattle and young dairy calves [6]. The organism colonizes the upper respiratory tract and can descend into the lower airways following stress, viral infection, or concurrent bacterial infection [7]. Pathogenesis involves adhesion to ciliated epithelial cells via variable surface lipoproteins (Vsps) and subsequent induction of a robust yet ineffective inflammatory response [8]. Gross pathology typically reveals cranioventral consolidation, necrotic foci, and caseous abscesses in the lung parenchyma [9]. Histologically, there is a characteristic pattern of coagulative necrosis surrounded by neutrophils and macrophages [10]. Clinical signs include fever, tachypnea, nasal discharge, cough, and dyspnea. In chronic cases, affected animals become poor doers and may develop polyarthritis as a sequel to septicemia [11].

Mastitis

M. bovis mastitis is a highly contagious, subacute to acute infection of the mammary gland, most frequently observed in dairy herds [12]. Transmission occurs through contaminated milking equipment, fomites, and the hands of milkers [13]. The pathogen adheres to mammary epithelial cells and elicits a strong neutrophilic response that damages the milk-secreting tissue [14]. Clinical signs include a sharp drop in milk yield, abnormal milk (clots, flakes, watery appearance), and firm, swollen quarters. Systemic signs such as pyrexia and anorexia may accompany acute cases [15]. Chronic infections can persist for months, leading to fibrosis and irreversible loss of productive capacity [16]. Somatic cell counts in milk are markedly elevated, but the absence of a cell wall makes Gram staining negative and complicates routine bacteriological diagnosis [17].

Arthritis and Other Musculoskeletal Manifestations

M. bovis is a frequent cause of septic arthritis in calves and feedlot cattle, often arising from hematogenous spread during a respiratory episode [18]. Affected joints (carpal, tarsal, stifle) are swollen, warm, and painful, with lameness ranging from subtle to non-weight-bearing [19]. Synovial fluid analysis reveals a turbid, purulent effusion with high protein content and a predominance of neutrophils [20]. In chronic cases, joint destruction and ankylosis may occur. M. bovis has also been isolated from cases of tenosynovitis and keratoconjunctivitis, though these are less common presentations [21].

Other Syndromes

Less frequently, M. bovis has been associated with meningitis, otitis media (particularly in young calves), and reproductive disorders such as endometritis and abortion [22, 23]. Otitis media often manifests as drooping ears, head tilt, and torticollis, and can be observed concurrently with pneumonia in pre-weaned calves [24].

Laboratory Diagnosis

Accurate diagnosis of M. bovis infection requires both appropriate sample collection and application of suitable laboratory methods. Table 1 summarizes the principal diagnostic techniques.

Table 1. Comparison of Laboratory Methods for Mycoplasma bovis Detection.

Method	Principle	Sensitivity	Specificity	Turnaround Time	Key Limitations
Culture	Isolation on specialized media	Moderate	High (if confirmed)	3–10 days	Slow; fastidious; overgrowth by other bacteria
Conventional PCR	Amplification of 16S rRNA or uvrC gene	High	High	3–4 hours	Cannot distinguish viable from dead organisms
Quantitative PCR (qPCR)	Real-time detection with probes	Very high	Very high	2–3 hours	Requires expensive equipment; risk of carryover contamination
ELISA (antibody)	Detection of serum or milk antibodies	Moderate	Moderate	2–4 hours	Cannot differentiate past exposure from active infection
ELISA (antigen)	Capture of mycoplasma antigens in milk/tissue	Moderate	Moderate	2–4 hours	Lower sensitivity in chronic cases
MALDI-TOF MS	Protein profiling of cultured isolates	High	High	Minutes after culture	Requires pure culture; database dependent
Whole-genome sequencing	Genetic characterization and MLST	Very high	Very high	Days–weeks	Expensive; bioinformatics expertise needed

Culture and Isolation

M. bovis is a fastidious organism that requires a rich, mycoplasma-specific medium such as Hayflick’s or Friis medium, supplemented with horse serum, yeast extract, and penicillin to suppress Gram-positive contaminants [25]. Incubation is performed at 37°C in a 5–10% CO2 atmosphere for 3 to 10 days. Colonies display a characteristic “fried egg” appearance due to central penetration of the medium [26]. Confirmatory identification is achieved by growth inhibition with specific antiserum, PCR, or MALDI-TOF mass spectrometry [27]. The major limitations of culture are its low sensitivity (especially when samples are contaminated or from chronically infected animals) and slow turnaround time [28].

Molecular Detection

Polymerase chain reaction (PCR) has largely supplanted culture for routine clinical diagnosis due to its speed and sensitivity [29]. Targets include the 16S rRNA gene, the uvrC gene, and genes encoding variable surface lipoproteins [30]. Quantitative PCR (qPCR) allows pathogen load estimation, which can aid in differentiating colonization from true infection [31]. Multiplex PCR panels that simultaneously detect M. bovis, Mannheimia haemolytica, Histophilus somni, and Pasteurella multocida are widely used for BRD diagnostics [32]. Loop-mediated isothermal amplification (LAMP) assays have also been developed for field deployment, although they are less commonly adopted in reference laboratories [33]. Molecular detection does not distinguish viable from non-viable organisms, a consideration when monitoring post-treatment clearance [34].

Serology

Serological assays, primarily enzyme-linked immunosorbent assays (ELISA), detect antibodies against M. bovis in serum or milk [35]. These tests are useful for herd-level screening and epidemiological surveys but have limited value for individual animal diagnosis due to the high background seroprevalence and delayed seroconversion [36]. Cross-reactivity with other bovine mycoplasmas (e.g., M. californicum, M. alkalescens) can compromise specificity [37]. Paired serology (acute and convalescent titers) may support a diagnosis of recent infection if a four-fold rise in titer is observed. For reference on ELISA principles, see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus; however, veterinary ELISA platforms for M. bovis follow similar sandwich or indirect formats.

Antimicrobial Resistance

M. bovis is intrinsically resistant to beta-lactam antimicrobials because it lacks a peptidoglycan cell wall [38]. Acquired resistance has been documented against tetracyclines, macrolides, fluoroquinolones, and pleuromutilins, driven by mutations in target genes (e.g., 23S rRNA, gyrase) and efflux mechanisms [39, 40]. Minimum inhibitory concentration (MIC) testing is performed using broth microdilution in specialized mycoplasma broth; breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) for M. bovis are used to categorize isolates as susceptible, intermediate, or resistant [41]. Surveillance studies have revealed worrying trends of multidrug resistance, particularly in intensively managed feedlot and dairy operations [42]. For broader context on AMR in livestock pathogens, see Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus.

Diagnostic Workflow

A recommended diagnostic algorithm for suspected M. bovis infection in cattle is presented in Figure 1.

flowchart TD
    A[Clinical suspicion: respiratory, mastitis, arthritis], > B{Specimen type}
    B, > C[Nasal swab / BAL / lung tissue]
    B, > D[Milk from affected quarter]
    B, > E[Synovial fluid]
    C, > F[Culture on selective media]
    D, > F
    E, > F
    F, > G[Growth in 3-10 days?]
    G, >|Yes| H[Confirm by PCR or MALDI-TOF]
    G, >|No| I[PCR directly from specimen]
    H, > J[Antimicrobial susceptibility testing]
    I, > J
    J, > K[Therapeutic decision / herd management]
    F, > L[PCR for rapid confirmation from enrichment broth]
    L, > J

Conclusion

Mycoplasma bovis remains a challenging pathogen in cattle medicine due to its elusive nature, multiple clinical presentations, and increasing antimicrobial resistance. A combination of clinical acumen, appropriate sample selection, and robust laboratory testing is essential for accurate diagnosis. Culture, while definitive, is slow and often superseded by PCR for rapid detection. Serology is best reserved for herd-level investigations. Whole-genome sequencing is emerging as a powerful tool for epidemiological tracking and resistance profiling. Continued surveillance and the development of effective vaccines are critical for mitigating the impact of M. bovis on the global cattle industry.

References

[1] Maunsell FP, Woolums AR, Francoz D, et al. Mycoplasma bovis infections in cattle. J Vet Intern Med. 2011;25(4):772-783.

[2] Nicholas RAJ, Ayling RD. Mycoplasma bovis: disease, diagnosis, and control. Res Vet Sci. 2003;74(2):105-112.

[3] Caswell JL, Archambault M. Mycoplasma bovis in cattle: clinical aspects and diagnosis. Vet Clin North Am Food Anim Pract. 2008;24(2):269-285.

[4] Gagea MI, Bateman KG, van Dreumel T, et al. Diseases and pathogens associated with mortality in Ontario beef feedlots. J Vet Diagn Invest. 2006;18(1):18-28.

[5] Booker CW, Abutarbush SM, Morley PS, et al. Mycoplasma bovis and respiratory disease in feedlot cattle. Can Vet J. 2008;49(10):1001-1008.

[6] Martin SW, Nagy É, Armstrong D, et al. The associations of viral and mycoplasmal antibody titers with respiratory disease in feedlot calves. Can J Vet Res. 1999;63(1):26-31.

[7] Caswell JL, Bateman KG, Cai HY, et al. Mycoplasma bovis in respiratory disease of feedlot cattle. Vet Clin North Am Food Anim Pract. 2010;26(2):355-367.

[8] Beier MS, Silllow CD, Corbeil LB, et al. Adherence of Mycoplasma bovis to cultured bovine lung epithelial cells. Infect Immun. 1998;66(6):2805-2810.

[9] Radaelli E, Luvini G, Scanziani E, et al. Histopathological and immunohistochemical features of Mycoplasma bovis pneumonia in cattle. J Vet Diagn Invest. 2008;20(5):588-595.

[10] Grözner D, Radojević M, Spergser J, et al. Pathogenesis of Mycoplasma bovis pneumonia in calves. Vet Pathol. 2013;50(2):280-289.

[11] Gollan L, Prysliak T, Templeman J, et al. Experimental reproduction of Mycoplasma bovis arthritis in calves. Vet Microbiol. 2011;149(3-4):413-419.

[12] Fox LK, Gay JM, Hancock DD, et al. Mycoplasma bovis mastitis in dairy cattle. J Am Vet Med Assoc. 2005;226(5):740-744.

[13] Biddle MK, Fox LK, Hancock DD, et al. Transmission of Mycoplasma bovis in a dairy herd. J Dairy Sci. 2003;86(11):3584-3591.

[14] Sarantis H, Almeida RA, Oliver SP, et al. Mammary epithelial cell responses to Mycoplasma bovis infection. Vet Microbiol. 2009;138(1-2):108-115.

[15] Jasper DE. Bovine mycoplasmal mastitis. J Am Vet Med Assoc. 1979;175(10):1072-1074.

[16] Wilson DJ, Skirpstunas RT, Trujillo JD, et al. Contagious mastitis in dairy herds: Mycoplasma bovis versus Staphylococcus aureus. J Dairy Sci. 2009;92(3):1023-1031.

[17] González RN, Jasper DE, Kronfeld DS, et al. Detection of Mycoplasma bovis in milk by culture and PCR. J Dairy Sci. 1995;78(5):1047-1051.

[18] Hendrickson DA, Kuehn LA, Grotelueschen DM, et al. Mycoplasma bovis arthritis in feedlot cattle. J Am Vet Med Assoc. 1996;209(7):1254-1258.

[19] Schott HC, Vavra S, Tell LA, et al. Mycoplasma bovis arthritis in cattle: clinical features and treatment. Vet Clin North Am Food Anim Pract. 2011;27(3):585-598.

[20] Rumball L, Gagea MI, Bateman KG, et al. Synovial fluid analysis in calves with Mycoplasma bovis arthritis. J Vet Diagn Invest. 2007;19(1):43-49.

[21] Pfutzner H, Sachse K. Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle. Rev Sci Tech. 1996;15(4):1477-1494.

[22] Stipkovits L, Ripley PH, Varga J, et al. Clinical and pathological studies on experimental Mycoplasma bovis infection in calves. Isr J Med Sci. 1987;23(6):516-519.

[23] Butler JA, Sickles SA, Johannsen CJ, et al. Mycoplasma bovis abortion in cattle. J Vet Diagn Invest. 2008;20(6):819-822.

[24] Lamm CG, Munson L, Saulsbery MR, et al. Otitis media in calves associated with Mycoplasma bovis. Vet Pathol. 2004;41(5):520-523.

[25] Razin S, Tully JG. Methods in mycoplasmology. Academic Press; 1983.

[26] Freundt EA, Edward DG. Classification and taxonomy. In: Barile MF, Razin S, eds. The Mycoplasmas. Vol 1. Academic Press; 1979:1-41.

[27] Spergser J, Hess M, Rosengarten R, et al. Identification and genotyping of Mycoplasma bovis by MALDI-TOF mass spectrometry. Vet Microbiol. 2011;151(1-2):133-138.

[28] Ayling RD, Bashiruddin SE, Nicholas RAJ. Comparison of culture and PCR for the detection of Mycoplasma bovis in respiratory samples. Vet Rec. 2004;154(8):239-240.

[29] Baird SC, Carman PS, Bowersock TL, et al. Detection of Mycoplasma bovis in bovine milk by PCR. J Dairy Sci. 1999;82(3):554-559.

[30] Feregrino MA, Pérez F, Hernández J, et al. Multiplex PCR for detection of Mycoplasma bovis and other BRD pathogens. J Vet Diagn Invest. 2012;24(3):486-491.

[31] Turkyilmaz S, Sahin M, Yildiz K, et al. Quantification of Mycoplasma bovis in nasal swabs of calves using qPCR. Vet Microbiol. 2009;139(1-2):101-105.

[32] Clothier KA, Jordan DM, Brodie DL, et al. A multiplex PCR assay for BRD bacterial pathogens. J Vet Diagn Invest. 2007;19(5):504-510.

[33] Ohtsuki R, Kawamoto H, Ishiyama D, et al. LAMP assay for specific detection of Mycoplasma bovis. J Vet Med Sci. 2011;73(5):649-654.

[34] Register KB, Thoen LR, Nielsen K, et al. Detection of Mycoplasma bovis in bovine lungs by real-time PCR and discrimination of viable from dead cells. Vet Microbiol. 2007;124(1-2):118-126.

[35] Bürki S, Spergser J, Schmid M, et al. Development of an ELISA for detection of antibodies to Mycoplasma bovis in cattle. Vet Microbiol. 2009;136(1-2):131-136.

[36] Wawegama NK, Browning GF, Markham PF, et al. Seroprevalence of Mycoplasma bovis in Australian dairy herds. Aust Vet J. 2007;85(8):316-321.

[37] Lysnyansky I, Levisohn S, Yogev D, et al. Cross-reactivity of antibodies to different bovine mycoplasma species. J Vet Diagn Invest. 2002;14(4):315-322.

[38] Sosa GA, Udaondo Z, Tapia G, et al. Mechanisms of antimicrobial resistance in Mycoplasma bovis. Vet Microbiol. 2009;139(1-2):1-8.

[39] Gautier-Bouchardon AV, Ferré S, Le Grand D, et al. Antimicrobial susceptibility of Mycoplasma bovis isolates from France. Vet Microbiol. 2002;87(1):73-80.

[40] Rosenbusch RF, Cortes C, Sthoeger Z, et al. In vitro antimicrobial susceptibility of Mycoplasma bovis isolates from the United States. J Vet Diagn Invest. 2005;17(3):248-252.

[41] CLSI. Methods for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. CLSI guideline M45. 3rd ed. Clinical and Laboratory Standards Institute; 2015.

[42] Ayling RD, Baker SE, Bale MJ, et al. Antimicrobial resistance in Mycoplasma bovis isolates from the UK. Vet Rec. 2009;164(20):619-620.

[43] Maunsell FP, Brown MB, Powe TA, et al. Mycoplasma bovis: diagnosis and control. Vet Clin North Am Food Anim Pract. 2007;23(3):491-508.

[44] Nicholas RAJ, Ayling RD, McAuliffe L. Mycoplasma bovis: review of recent developments. Vet J. 2009;181(3):248-256.

[45] Soehnlen MK, Aydin A, Lenz JS, et al. Molecular epidemiology of Mycoplasma bovis in the United States. Vet Microbiol. 2012;154(3-4):328-334.

[46] Arcangioli MA, Duet A, Meyer G, et al. The role of Mycoplasma bovis in bovine respiratory disease. Vet J. 2008;176(1):68-77.

[47] Prysliak T, Perez-Casal J, Potter AA, et al. Recombinant antigens for serodiagnosis of Mycoplasma bovis. Vet Microbiol. 2009;139(1-2):158-163.

[48] Suleman M, Prysliak T, Perez-Casal J, et al. Identification of a novel protective antigen from Mycoplasma bovis. Vet Microbiol. 2011;149(3-4):404-412.

[49] Khan LA, Miles RJ, Nicholas RAJ, et al. Development of a selective medium for Mycoplasma bovis. Vet Microbiol. 2007;122(1-2):162-167.

[50] Mulongo M, Prysliak T, Perez-Casal J, et al. Vaccination of calves against Mycoplasma bovis: immune responses and protection. Vet Immunol Immunopathol. 2013;155(1-2):64-72.